Filing Details
Gossamer Bio, Inc. (NASDAQ:GOSS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 10, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:GOSS
Gossamer Bio, Inc. (GOSS) Files Quarterly Report for Q0
Gossamer Bio, Inc. (NASDAQ:GOSS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 10, 2026.
At publication ·
What changed
Gossamer Bio, Inc. (NASDAQ:GOSS) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Gossamer Bio filed its quarterly report (Form 10-Q) with the SEC on November 10, 2026.
- The healthcare company's stock trades at $11.28 with a market capitalization of $824.3 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
Gossamer Bio, Inc.'s stock currently trades at $11.28 with a market capitalization of $824.3M.
The 10-Q provides Gossamer Bio, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Gossamer Bio, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GOSS Stock Page
Frequently Asked Questions
Where can I read GOSS's SEC filings?
Browse all filings on our GOSS SEC filings page.
What types of SEC filings does Gossamer Bio, Inc. file?
Public companies like Gossamer Bio, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.